INTRODUCTION:

The 21st century has been marked by a series of pivotal viral outbreaks, each presenting unique challenges to global health, societies, and economies.

The emergence of novel viruses and subsequent pandemics has reshaped public health strategies, altered societal norms, and emphasized the imperative for rapid and coordinated responses to infectious diseases. Notably, the early years of this century witnessed the rise of unprecedented threats, beginning with the advent of Severe Acute Respiratory Syndrome (SARS) in 2002. This marked the onset of a cascade of pandemics that tested the resilience of healthcare systems and underscored the importance of international collaboration in combating emerging infectious diseases.

SARS-CoV, the causative agent behind SARS, emerged in late 2002, originating in Guangdong Province, China. Its swift international transmission resulted in over 8, 000 cases across 26 countries. The rapid global response and containment efforts curbed the outbreak by mid-2003, demonstrating the power of coordinated action against novel viral threats.¹

Following the SARS outbreak, the world faced the influenza A H1N1 pdm 2009 virus, commonly known as swine flu, originating from a genetic combination of avian, swine, and human influenza viruses. The H1N1 pandemic, declared by the World Health Organization (WHO) in 2009, highlighted the virus's high transmissibility and prompted extensive vaccination campaigns to mitigate its impact on vulnerable populations.^2,3

Subsequently, the emergence of Middle East Respiratory Syndrome (MERS) in 2012 caused sporadic cases primarily in the Middle East. Although less widespread, MERS-CoV's high mortality rate accentuated the critical need for surveillance, swift responses, and research into potential treatments.^4,5

However, the most profound and enduring global health crisis of the 21st century emerged with the appearance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)⁵ and the subsequent COVID-19 pandemic. Originating in late 2019, this virus swiftly escalated into a global health emergency, overwhelming healthcare systems, triggering economic downturns, and altering everyday life on an unprecedented scale.^6,7

Apart from these significant outbreaks, other viruses have demanded attention in the 21st century, including the Ebola virus, which reemerged in several outbreaks, notably the West Africa outbreak of 2014-2016,⁸ and the Zika virus, particularly concerning its implications for pregnant women and infants due to its association with microcephaly.⁹Chikungunya^10,and Dengue¹¹ outbreaks also created major global impact.

The emergence and evolution of these viruses have underscored the interconnectedness of global health, the need for robust healthcare infrastructure, and the importance of proactive and coordinated responses to mitigate the impact of emerging infectious diseases. This compilation of viral outbreaks in the 21st century has reshaped our understanding of pandemics, emphasizing the necessity for preparedness, resilience, and international cooperation in safeguarding global health.

EMERGING VIRUSES AND GREAT PANDEMICS OF THE 21^ST CENTURY:

The first emerging virus and pandemic of the 21^st century: severe acute respiratory syndrome (SARS):

Severe Acute Respiratory Syndrome (SARS) was the first significant pandemic of the 21st century that emerged in late 2002 and continued into 2003. It was caused by a novel coronavirus called SARS-CoV, believed to have originated in bats and transmitted to humans, possibly through intermediary animals like civet cats in China's Guangdong province.

Overview of SARS:

· Emergence: The first cases of SARS were reported in November 2002 in Guangdong Province, China. Initially, the cause of the illness was unknown, presenting as atypical pneumonia. By early 2003, the outbreak had spread within China and soon internationally through infected travelers. In March 2003, a novel coronavirus, later named SARS-CoV, was identified as the cause of the disease.

· Spread and Transmission: SARS-CoV primarily spread through respiratory droplets when an infected person coughed or sneezed. It also had the potential for transmission through direct contact or via contaminated surfaces.

· Symptoms: SARS typically started with flu-like symptoms such as fever, cough, muscle aches, and general malaise. As the disease progressed, it could lead to severe respiratory distress and pneumonia.

· Global Impact: The outbreak spread to several countries around the world, affecting over 8, 000 people across 26 countries. The World Health Organization (WHO) declared it a global health threat and issued travel advisories and recommendations to control its spread.

· Challenges: The outbreak posed several challenges, including difficulties in identifying and isolating cases due to its initially unclear etiology, rapid spread through international travel, and shortcomings in infection control practices.

· Control Measures: Public health interventions such as quarantine measures, isolation of suspected cases, travel restrictions, and infection control practices in healthcare settings were crucial in controlling the spread of SARS. Rapid identification of cases and contact tracing played a significant role in preventing its further transmission.

· Containment: The global response to SARS was swift and coordinated, leading to containment of the outbreak. Enhanced surveillance, prompt isolation of cases, and stringent infection control measures contributed to the decline and eventual containment of the disease.

· Lessons Learned: The SARS outbreak highlighted the importance of global cooperation, early detection, rapid response, and transparency in dealing with emerging infectious diseases. It also spurred research and preparedness efforts to tackle future potential pandemics.

By mid-2003, the SARS outbreak was effectively contained, and no new cases were reported. However, the experience with SARS paved the way for increased preparedness and vigilance against emerging infectious diseases, setting the stage for responses to subsequent outbreaks such as the H1N1 influenza pandemic in 2009 and, more notably, the COVID-19 pandemic that began in late 2019.^{1, 12}

The second emerging virus and pandemic of the 21st century: Influenza H1N1 pdm 2009

Influenza A H1N1 pdm 2009, commonly known as the swine flu, was a subtype of the Influenza A virus that caused a global pandemic in 2009 and 2010.

Overview of influenza H1N1 pdm 2009:

· Emergence: The H1N1 pdm 2009 virus originated from a combination of genetic material from pigs, humans, and birds. It was identified in April 2009 and was named "swine flu" initially because its genetic makeup resembled viruses that commonly circulate in pigs. However, it was a unique strain that had not been previously identified in humans.

· Spread and Transmission: Like other influenza viruses, H1N1 pdm 2009 primarily spread through respiratory droplets when an infected person coughed, sneezed, or talked. It was highly contagious and easily transmitted from person to person, contributing to its rapid global spread.

· Symptoms: The symptoms of H1N1 pdm 2009 were similar to those of seasonal flu and included fever, cough, sore throat, body aches, fatigue, headache, chills, and in some cases, diarrhea and vomiting. The severity of symptoms varied among individuals, with some experiencing mild illness while others faced more severe complications.

· Risk Groups: Certain groups were at higher risk of developing severe complications from the H1N1 virus, including pregnant women, young children, the elderly, individuals with underlying health conditions (such as asthma, diabetes, or heart disease), and those with weakened immune systems.

· Global Impact: The World Health Organization (WHO) declared H1N1 pdm 2009 a pandemic in June 2009 due to its rapid spread across multiple countries and continents. Governments and health organizations worldwide mobilized efforts to control its transmission, manage cases, and minimize its impact on public health.

· Response and Measures: Various measures were implemented to contain the spread of the virus, including public health campaigns promoting hygiene practices, mask-wearing, social distancing, school closures, travel restrictions, and vaccination campaigns once a vaccine became available.

· Vaccine Development: Vaccines specific to the H1N1 pdm 2009 strain were developed and distributed globally. These vaccines were intended to provide immunity against the virus and reduce its transmission. Initially, due to limited production, priority groups, such as healthcare workers and high-risk individuals, were recommended to receive the vaccine first.

· Subsiding and Evolution: Over time, as more people were exposed to the virus and vaccination efforts continued, immunity in the population increased. The H1N1 pdm 2009 virus eventually became one of the seasonal influenza strains, causing milder illness compared to its initial pandemic phase.

Influenza A H1N1 pdm 2009 was a novel strain of influenza that caused a global pandemic, leading to significant public health responses aimed at containing its spread, managing cases, and developing vaccines to mitigate its impact on populations worldwide.^2,3,13Bottom of Form

The third emerging virus and pandemic of the 21st century: Middle east respiratory syndrome (MERS)

Middle East Respiratory Syndrome (MERS) was another significant pandemic of the 21st century caused by the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Here

Overview of MERS:

· Emergence: MERS was first identified in Saudi Arabia in 2012. It primarily affected countries in the Middle East, with sporadic cases reported in other regions through travel-associated spread.

· Spread and Transmission: MERS-CoV is believed to originate from dromedary camels, which serve as an animal reservoir for the virus. Human-to-human transmission occurs, primarily through close contact with infected individuals, especially in healthcare settings.

· Symptoms: MERS typically presents with symptoms such as fever, cough, shortness of breath, and pneumonia. It can lead to severe respiratory illness and, in some cases, respiratory failure and death, particularly among individuals with underlying health conditions.

· Global Impact: The MERS outbreak remained sporadic, with fewer cases reported compared to other respiratory infections. However, the mortality rate was relatively high, around 35%, indicating the severity of the disease.

· Control Measures: Public health measures focused on surveillance, contact tracing, isolation of suspected cases, and infection control practices in healthcare settings. Travel advisories were issued for affected areas, emphasizing precautions for travelers.

· Research and Preparedness: The emergence of MERS prompted extensive research to understand the virus, its transmission dynamics, and potential treatment and vaccine development. It highlighted the importance of global cooperation in addressing emerging infectious diseases.

MERS-CoV continues to circulate, causing occasional cases, but sustained community transmission leading to widespread outbreaks has not occurred. Nevertheless, ongoing surveillance, research, and preparedness efforts remain essential to monitor the virus and prevent potential future outbreaks.^4,5,14

The fourth pandemic of the 21st century -SARS CoV-2 (COVID -19):

The fourth pandemic of the 21st century is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to the COVID-19 disease. It belongs to the family of coronaviruses, which also includes viruses that cause illnesses ranging from the common cold to more severe diseases like Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The exact origin of the virus is believed to be zoonotic, likely originating from bats and potentially transmitted to humans through an intermediate animal host, although this has not been definitively confirmed.

· Emergence and Spread: SARS-CoV-2 was first identified in December 2019 in Wuhan, China, and quickly evolved into a global health crisis. It is believed to have originated from a seafood market where live wild animals were also sold, though the exact origin is still under investigation. Due to its high transmissibility and asymptomatic spread, the virus rapidly spread across countries and continents, leading to the declaration of a pandemic by the World Health Organization (WHO) in March 2020.

· Transmission: The virus primarily spreads through respiratory droplets when an infected person coughs, sneezes, talks, or even breathes. It can also spread by touching surfaces contaminated with the virus and then touching the face, particularly the eyes, nose, or mouth. One of the challenges of COVID-19 is its ability to spread from individuals who may not show symptoms (asymptomatic) or from those in the pre-symptomatic phase.

· Symptoms: COVID-19 symptoms range from mild to severe and can appear 2-14 days after exposure to the virus. Common symptoms include fever, cough, shortness of breath, fatigue, muscle or body aches, loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, and diarrhea. In severe cases, the virus can lead to pneumonia, acute respiratory distress syndrome (ARDS), organ failure, and death.

· Severity and Risk Groups: While COVID-19 can affect individuals of all ages, older adults and those with underlying health conditions such as diabetes, heart disease, chronic respiratory conditions, and weakened immune systems are at a higher risk of severe illness or complications.

· Global Impact: The COVID-19 pandemic profoundly impacted public health, economies, social interactions, and healthcare systems worldwide. Governments implemented various measures such as lockdowns, travel restrictions, mask mandates, social distancing, and widespread testing to control the spread of the virus.

· Vaccine Development and Treatment: Efforts were made worldwide to develop vaccines against COVID-19. Multiple vaccines were developed and authorized for emergency use within an unprecedented timeframe. Vaccination campaigns aimed to provide immunity and reduce the spread of the virus. Additionally, various treatments, including antiviral medications, monoclonal antibodies, and corticosteroids, were used to manage symptoms and improve outcomes for those infected.

· Strain Variants and Evolution: SARS-CoV-2 continuously evolves, resulting in the emergence of different variants with varying transmissibility, severity, and potential impacts on vaccine effectiveness. Monitoring and studying these variants have been crucial in understanding the virus's behavior and adapting public health strategies accordingly.

· Long-Term Impact: The pandemic has had far-reaching consequences on global health, economies, education, mental health, and societal structures. It exposed weaknesses in healthcare systems, widened socio-economic disparities, and altered daily life, with the widespread adoption of remote work, virtual communication, and changes in social interactions.

Efforts continue globally to control the spread of the virus, provide vaccines, enhance medical treatments, and adapt to the challenges posed by SARS-CoV-2, aiming to mitigate its long-term impact and restore societal stability and well-being.^7,7,12,14,15

OTHER VIRUSES AND PANDEMIC OF THE 21^ST CENTURY:

Ebola Virus:

The Ebola virus is a highly contagious and often fatal virus that causes severe illness in humans and other primates. The Ebola virus was first identified in 1976. The virus was named after the Ebola River in the Democratic Republic of Congo (formerly Zaire), where one of the first recognized outbreaks occurred near a village. The initial outbreak involved simultaneous cases in Sudan and the Democratic Republic of Congo, now known as South Sudan and the Democratic Republic of Congo, respectively. These outbreaks marked the first known instances of the Ebola virus causing severe illness and death in humans. in February 2021, a new Ebola outbreak was declared in the North Kivu Province of the Democratic Republic of Congo. This outbreak emerged while the country was already dealing with another Ebola outbreak in the western Equateur Province. Efforts were made to contain the spread of the virus, and vaccination campaigns were conducted. Another outbreak occurred in the North Kivu Province of the DRC in August 2018. This outbreak was particularly challenging due to the region's ongoing conflicts and instability, hindering response efforts. The outbreak was declared over in June 2020 after causing numerous cases and fatalities. West Africa 2014-2016 was one of the largest and most devastating Ebola outbreaks in history. It started in Guinea in December 2013 and later spread to Liberia and Sierra Leone. The outbreak resulted in more than 28, 000 reported cases and over 11, 000 deaths. It significantly affected the region, causing social disruption and economic challenges.

Overview of Ebola virus:

· Virus and Types: Ebola virus is a member of the Filoviridae family, with five identified species: Zaire ebolavirus (EBOV), Sudan ebolavirus (SUDV), Bundibugyo ebolavirus (BDBV), Taï Forest ebolavirus (TAFV), and Reston ebolavirus (RESTV). The first four species are known to cause illness in humans, while RESTV has caused illness in non-human primates but not in humans, except for mild symptoms.

· Origin and Transmission: The Ebola virus is believed to originate from animals, particularly bats, which are considered a natural reservoir for the virus. It can be transmitted to humans through the handling or consumption of infected animals (such as bats or non-human primates) or through contact with bodily fluids (blood, saliva, feces, urine) of infected individuals or deceased persons. Human-to-human transmission occurs through direct contact with the blood, secretions, organs, or bodily fluids of an infected person.

· Symptoms: The onset of Ebola symptoms typically occurs between 2 to 21 days after exposure to the virus. Symptoms can include sudden onset of fever, intense weakness, muscle pain, headache, sore throat, vomiting, diarrhea, rash, impaired kidney and liver function, and in severe cases, internal and external bleeding.

· Severity and Mortality: Ebola virus disease (EVD) can progress rapidly, leading to severe illness and high mortality rates. The fatality rate can vary among outbreaks and virus strains, ranging from 25% to 90%. Patients who survive may still experience long-term complications, including joint and vision problems, and other health issues.

· Outbreaks and Global Impact: Ebola outbreaks have historically occurred in Central and West Africa, primarily in regions where healthcare infrastructure is limited. The largest outbreak occurred in West Africa between 2014 and 2016, mainly affecting Guinea, Liberia, and Sierra Leone, resulting in thousands of deaths and significant socio-economic disruption.

· Prevention and Control: Preventing the spread of Ebola involves public health measures such as isolating infected individuals, tracing and monitoring contacts, practicing infection control in healthcare settings, implementing safe burial practices, and raising public awareness about prevention methods like hand hygiene and avoiding contact with infected persons or animals.

· Vaccine and Treatment: Efforts have been made to develop vaccines and treatments for Ebola. Several experimental vaccines have shown promising results in clinical trials and have been used in outbreak settings to help control the spread of the virus. Treatment primarily involves supportive care, such as maintaining hydration and electrolyte balance, managing symptoms, and providing appropriate medical care to improve the patient's chances of survival.

The Ebola virus is a severe and highly infectious virus that can cause outbreaks of Ebola virus disease, posing significant challenges to public health systems and requiring rapid and coordinated responses to contain its spread and mitigate its impact on affected communities.^8,
16

Zika virus:

The Zika virus is a mosquito-borne virus that belongs to the Flaviviridae family and is primarily transmitted to humans through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. The Zika virus, although known since the 1940s, gained significant attention due to a notable outbreak that occurred in the 21st century.

Overview of Zika virus

· Geographical Distribution: The Zika virus was first identified in 1947 in the Zika Forest of Uganda, where it was discovered in a rhesus monkey. Human cases were reported sporadically in Africa and Asia for several decades, but the virus did not attract widespread attention until a significant outbreak in the Western Hemisphere. The major outbreak that brought global attention to the Zika virus began in 2015 in Brazil. It quickly spread across South and Central America, the Caribbean, and parts of North America. This outbreak was marked by a surge in reported cases of Zika virus infection, particularly in Brazil, and raised concerns due to the observed link between Zika virus infection during pregnancy and birth defects, particularly microcephaly in newborns.

· Transmission: The virus gained attention due to its rapid spread and the concerning association with birth defects and neurological complications. The primary mode of transmission is through the bite of infected mosquitoes, which primarily feed during the daytime. Zika virus can also be transmitted through sexual contact, from mother to child during pregnancy or childbirth, and in rare cases, through blood transfusions or organ transplantation.

· Concerns for Pregnant Women and other complication: One of the most alarming aspects of the Zika virus outbreak was its link to congenital abnormalities, particularly microcephaly, where babies were born with abnormally small heads and potential developmental issues due to brain damage. Pregnant women were advised to take precautions against Zika virus infection, and travel warnings were issued for regions affected by the outbreak. Zika virus infection has also been linked to Guillain-Barré syndrome, a rare neurological disorder.

· Prevention and Control: Preventing mosquito bites is crucial in reducing the risk of Zika virus transmission. This includes using insect repellents, wearing long-sleeved clothing, using mosquito nets, and eliminating breeding sites for mosquitoes (stagnant water in containers, tires, etc.). Pregnant women or those planning to become pregnant are advised to avoid travel to areas with ongoing Zika outbreaks.

· Diagnosis and Treatment: Diagnosing Zika virus infection can be done through specific laboratory tests that detect the virus's genetic material in blood or other bodily fluids. There is no specific antiviral treatment for Zika virus. Supportive care, such as rest, hydration, and pain relief, is recommended for symptomatic individuals.

· Research and Response: Since the 2015 outbreak, significant research efforts have focused on understanding the virus, its transmission dynamics, and its impact on human health, especially concerning pregnancy. Public health responses have aimed at mosquito control measures, surveillance, and public awareness campaigns to prevent transmission.

Though the intensity of the outbreak declined in subsequent years, the Zika virus outbreak of 2015-2016 significantly raised awareness about the potential health risks associated with the virus, especially for pregnant women and their babies. Ongoing vigilance and research efforts continue to monitor and understand the Zika virus's impact and transmission dynamics to prevent future outbreaks and mitigate its effects on public health.^{7, 17, 18}

Chikungunya virus:

Chikungunya virus was first identified during an outbreak in Tanzania in 1952. The name "Chikungunya" is derived from a word in the Kimakonde language, meaning "to become contorted," describing the stooped appearance of individuals affected by the severe joint pain characteristic of the disease.

Over view of Chikungunya virus

· Geographical Distribution: Chikungunya, although known for decades, gained significant attention in the 21st century due to its geographical expansion and large-scale outbreaks in new regions outside its traditional range. One of the significant events that brought attention to Chikungunya in the 21st century was the outbreak in the Indian Ocean islands. The outbreak began in 2005 on the island of La Réunion and rapidly spread to neighboring islands and parts of India. This outbreak affected hundreds of thousands of people and drew global attention due to its magnitude and the high number of cases reported. Chikungunya continued its spread beyond Africa and the Indian Ocean islands, reaching various parts of Asia, including countries like India, Thailand, and the Philippines. Additionally, the virus made its way to the Americas, causing outbreaks in regions like the Caribbean, Central and South America, where it had not been previously established

· Transmission: The Chikungunya virus is transmitted to humans through the bite of infected mosquitoes, primarily Aedes species. These mosquitoes are active during the day, and an infected mosquito can transmit the virus by biting a person. The virus does not spread directly from person to person.

· Symptoms: Chikungunya infection typically leads to an abrupt onset of symptoms after an incubation period of 2 to 12 days. Common symptoms include sudden fever, severe joint pain (mainly in the hands and feet), muscle pain, headache, nausea, fatigue, and rash. Joint pain associated with Chikungunya infection can be debilitating and persist for weeks to months, leading to severe joint inflammation and stiffness.

· Impact and Complications: While Chikungunya is rarely fatal, the symptoms can be severe and disabling, causing considerable discomfort and hindering daily activities due to joint pain and stiffness. In some cases, the infection can lead to long-term joint problems, including chronic arthritis, which may persist for months or even years after the acute phase of the illness.

· Diagnosis and Treatment: Diagnosing Chikungunya involves laboratory tests to detect the presence of the virus in the blood. There is no specific antiviral treatment for Chikungunya, so medical care focuses on managing symptoms. Rest, hydration, pain relievers (such as acetaminophen), and anti-inflammatory medications may be recommended to alleviate symptoms.

· Prevention: Preventing Chikungunya involves reducing exposure to mosquito bites. This includes using insect repellents, wearing long-sleeved clothing and pants, using mosquito nets, and eliminating potential breeding sites for mosquitoes around homes (removing stagnant water in containers, covering water storage, etc.).

· Global Health Concern: Chikungunya outbreaks pose a public health concern due to the potential for rapid spread, the impact on affected individuals' quality of life, and the potential burden on healthcare systems, especially in regions where the virus is not endemic.

In conclusion, Chikungunya is a viral disease transmitted by mosquitoes that can cause significant discomfort and joint-related complications. Prevention through mosquito bite avoidance remains the primary method to reduce the risk of infection, particularly for travelers visiting areas where Chikungunya is prevalent.^10,19

Dengue virus:

Dengue fever has been a significant public health concern for several decades, but its emergence and resurgence in the 21st century have been notable due to increased incidence, geographic spread, and impact. Here's an overview of dengue's emergence in the 21st century:

Global Increase in Incidence: Dengue fever has shown a significant increase in incidence worldwide in the 21st century. It is estimated that around half of the world's population is at risk of dengue infection, with millions of cases reported annually. This increase in cases has been observed in various parts of the world, including Southeast Asia, the Americas, Africa, and the Western Pacific.

Overview of dengue virus:

· Expansion of Geographic Range: Dengue virus transmission has expanded to new geographic areas, including regions where the disease was not previously endemic. This expansion has been attributed to factors such as urbanization, increased travel and trade, population growth, inadequate sanitation, and the spread of the Aedes mosquitoes, the primary vectors for dengue transmission.

· Urbanization and Aedes Mosquitoes: Aedes aegypti and Aedes albopictus, the two primary mosquito species responsible for transmitting dengue virus, have adapted well to urban environments. These mosquitoes breed in stagnant water found in containers, discarded tires, and other artificial water-holding vessels commonly found in urban settings. Rapid urbanization has contributed to the proliferation of these vectors, increasing the risk of dengue transmission in urban areas.

· Impact on Public Health: Dengue fever poses a substantial burden on public health systems in affected regions, causing significant morbidity and mortality. Severe cases of dengue can lead to dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening without proper medical care. The disease's economic impact due to healthcare costs and lost productivity is also a concern.

· Climate Change and Environmental Factors: Changes in climate patterns, such as increased temperatures and rainfall, have been associated with the spread of dengue fever. These changes can create more favorable conditions for the breeding and survival of Aedes mosquitoes, potentially extending the geographic range of dengue transmission.

· Prevention and Control Efforts: Controlling the spread of dengue fever involves mosquito control measures, such as eliminating breeding sites, using insecticides, and community engagement in prevention strategies. Efforts to develop a dengue vaccine have also been ongoing, and several vaccines have been developed and approved for use in certain countries.

In summary, the emergence and resurgence of dengue fever in the 21st century have highlighted the need for continued efforts in surveillance, prevention, and control measures to mitigate the disease's impact and reduce its spread globally.^{101& 20}

CONCLUSION:

The 21st century has borne witness to a series of profound viral outbreaks that have reshaped our understanding of global health, compelling societies and healthcare systems worldwide to adapt rapidly to new challenges. From the emergence of Severe Acute Respiratory Syndrome (SARS) in 2002 to the relentless impact of the COVID-19 pandemic, each outbreak has underscored the critical importance of preparedness, global collaboration, and proactive responses to emerging infectious diseases.

These viral outbreaks have not only tested the resilience of healthcare infrastructure but also laid bare the interconnectedness of our world. They emphasized the necessity of robust surveillance systems, swift response mechanisms, and equitable access to healthcare resources. Lessons learned from SARS, H1N1, MERS, Ebola, Zika, Chikungunya, and Dengue outbreaks have ignited advancements in vaccine development, therapeutic interventions, and public health strategies.

The emergence and evolution of these viruses have necessitated continuous adaptation, urging societies to embrace innovative solutions, harness scientific advancements, and foster international solidarity. As we navigate the aftermath of these pandemics, the 21st century's lessons reaffirm the imperative of unified global efforts, resilient health systems, and unwavering commitment to safeguarding human health and well-being against the unpredictable nature of emerging infectious diseases.

Bottom of Form

CONFLICT OF INTEREST:

None.

REFERENCES:

1. LeDuc JW, Barry MA. SARS, the First Pandemic of the 21st Century. Emerg Infect Dis. 2004; 10(11): e26. doi: 10.3201/eid1011.040797_02.

2. Jilani TN, Jamil RT, Siddiqui AH. H1N1 Influenza. [Updated 2022 Oct 25]. In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. URL: https://www.ncbi.nlm.nih.gov/books/NBK513241/

3. Vasantha K, Mohanasundari SK. Awareness Regarding Influenza A (H1N1) Among Adults, AIIMS, Rishikesh. CPHN.2016 1(2): 125-130. DOI: 10.21088/cphn.2455.8621.1216.10.

4. Vasantha K, Mohanasundari SK. Middle East Respiratory Syndrome. CPHN. 2016 4(2): 1(2): 163-165. DOI: 10.21088/cphn.2455.8621.1216.17

5. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14(8): 523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27.

6. Mohan, R., Pandey, V., Gangadevi, P., Kurien, N., Joseph, J., & Mohanasundari, S. K. Anxiety among adolescent during COVID-19 pandemic: a cross-sectional study. International Journal Of Community Medicine And Public Health. 2022; 9(10): 3757–3762.doi: 10.18203/2394-6040.ijcmph20222568

7. Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, Dahal S, Kumar H, Kv D. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020; 96(1142): 753-758. doi: 10.1136/postgradmedj-2020-138234.

8. Jacob ST, Crozier I, Fischer WA 2nd, Hewlett A, Kraft CS, Vega MA, Soka MJ, Wahl V, Griffiths A, Bollinger L, Kuhn JH. Ebola virus disease. Nat Rev Dis Primers. 2020; 6(1): 13. doi: 10.1038/s41572-020-0147-3.

9. Plourde AR, Bloch EM. A Literature Review of Zika Virus. Emerg Infect Dis. 2016; 22(7): 1185-92. doi: 10.3201/eid2207.151990. Epub 2016 Jul 15. PMID: 27070380; PMCID: PMC4918175.

10. Silva LA, Dermody TS. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest. 2017; 127(3): 737-749. doi: 10.1172/JCI84417. Epub 2017 Mar 1.

11. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009; 22(4): 564-81. doi: 10.1128/CMR.00035-09.

12. Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol. 2020; 85: 104502. doi: 10.1016/j.meegid.2020.104502.

13. Elsabour Kinawy SA, Assalahi AA, Elnour Elshikh Ahmed G, Taha A, Abd Elgafar Hassan K, Wahdan Alrifai A, Helmy Elsaied M. COVID-19 and H1N1 Influenza: Are They 2 Sides of the Same Coin? Med J Islam Repub Iran. 2023; 37: 71. doi: 10.47176/mjiri.37.71.

14. Chafekar A, Fielding BC. MERS-CoV: Understanding the Latest Human Coronavirus Threat. Viruses. 2018; 10(2): 93. doi: 10.3390/v10020093.

15. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021; 13(2): 202. doi: 10.3390/v13020202.

16. Marcinkiewicz J, Bryniarski K, Nazimek K. Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention. Folia Med Cracov. 2014; 54(3): 39-48..

17. Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016; 29(3): 487-524. doi: 10.1128/CMR.00072-15.

18. Pielnaa P, Al-Saadawe M, Saro A, Dama MF, Zhou M, Huang Y, Huang J, Xia Z. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology. 2020; 543: 34-42. doi: 10.1016/j.virol.2020.01.015.

19. Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. Infect Dis Clin North Am. 2019; 33(4): 1003-1025. doi: 10.1016/j.idc.2019.08.006.

20. Khetarpal N, Khanna I. Dengue Fever: Causes, Complications, and Vaccine Strategies. J Immunol Res. 2016; 2016: 6803098. doi: 10.1155/2016/6803098.

Received on 14.12.2023 Modified on 04.01.2024

A and V Pub Int. J. of Nursing and Medical Res. 2024; 3(1):37-44.

DOI: 10.52711/ijnmr.2024.08